Does NEBIVOLOL Cause Patent ductus arteriosus? 7 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Patent ductus arteriosus have been filed in association with NEBIVOLOL (nebivolol). This represents 0.1% of all adverse event reports for NEBIVOLOL.
7
Reports of Patent ductus arteriosus with NEBIVOLOL
0.1%
of all NEBIVOLOL reports
0
Deaths
1
Hospitalizations
How Dangerous Is Patent ductus arteriosus From NEBIVOLOL?
Of the 7 reports, 1 (14.3%) required hospitalization.
Is Patent ductus arteriosus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEBIVOLOL. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does NEBIVOLOL Cause?
Hypotension (487)
Drug ineffective (430)
Bradycardia (371)
Dyspnoea (364)
Fall (320)
Acute kidney injury (300)
Dizziness (294)
Off label use (277)
Fatigue (257)
Hypertension (249)
What Other Drugs Cause Patent ductus arteriosus?
ONDANSETRON (185)
LAMOTRIGINE (168)
PAROXETINE (168)
ACETAMINOPHEN (154)
VENLAFAXINE (135)
SERTRALINE (130)
LEVETIRACETAM (122)
FLUOXETINE (107)
METOPROLOL (104)
RAMIPRIL (98)
Which NEBIVOLOL Alternatives Have Lower Patent ductus arteriosus Risk?
NEBIVOLOL vs NECITUMUMAB
NEBIVOLOL vs NEDAPLATIN
NEBIVOLOL vs NEFAZODONE
NEBIVOLOL vs NEFOPAM
NEBIVOLOL vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG